The Leading Source for Pharmaceutical & Biopharmaceutical Manufacturing News
Subscribe to Pharmaceutical Processing
View Sample

FREE Daily Email Newsletter

Study Lifts Cloud Over Heart Drugs Zetia, Vytorin

November 18, 2014 8:31 am | by MARILYNN MARCHIONE, AP Chief Medical Writer | News | Comments

A major study lifts a cloud around Zetia and Vytorin, blockbuster drugs for lowering cholesterol. The study found that these pills modestly lower the risk of heart attacks and other problems in people at high risk for them — evidence that's been missing for more than a decade as the drugs racked up billions in sales.


GlobalData Director: Actavis Continues Consolidation March with Highly Priced Allergan Deal

November 18, 2014 8:21 am | News | Comments

According to Joshua Owide, GlobalData’s Director of Healthcare Industry Dynamics, "The integration of Allergan and Forest will help grow Actavis to a $22 billion healthcare company in 2015. This is a dramatic elevation from its $8.7 billion revenues recorded in 2013, the year in which Actavis completed the $5 billion acquisition of Warner Chilcott."


Clovis Oncology and GSK to Collaborate on Oncology Clinical Trial

November 18, 2014 8:12 am | News | Comments

Clovis Oncology has entered into a clinical trial collaboration with GlaxoSmithKline to evaluate a novel combination therapy targeting mutant epidermal growth factor receptor (EGFR) non-small cell lung cancer (NSCLC).      


China Convicts Pharmaceutical Web Marketer in Anti-Rumor Campaign

November 18, 2014 8:06 am | News | Comments

A Beijing court has convicted an Internet marketer of illegal business practices and sentenced him to four years in prison for posting false information and deleting posts critical of his clients, in a case that state media have used to praise a government crackdown on online expression.


Zoetis Authorizes $500 Million Share Repurchase Program

November 18, 2014 8:02 am | News | Comments

Zoetis today announced that its Board of Directors has authorized a $500 million share repurchase program as part of its capital allocation plans. The shares are expected to be repurchased at the discretion of management, depending on market conditions and business needs.


INTERPHEX and Pharmaceutical Processing Announce Launch of INTERPHEX Live

November 17, 2014 4:06 pm | News | Comments

The premier, technology-focused 3-day video/talk show event presented live on the show floor during INTERPHEX 2015, April 21-23, 2015                    


The "Vaccine Court" Keeps Claimants Waiting

November 17, 2014 3:59 pm | by MITCH WEISS, Associated Press; JUSTIN PRITCHARD, Associated Press; TROY THIBODEAUX, Associated Press | News | Comments

To help people harmed by shots, Congress created the National Vaccine Injury Compensation Program. Government doctors and lawyers review claims. If they believe it is more likely than not that a vaccine — and not something else — caused the injury, they tap a $3.5 billion fund to pay for future care and lost wages. That fund is replenished by a 75-cent tax on each vaccine.


Nebraska Hospital: Surgeon with Ebola Has Died

November 17, 2014 3:44 pm | by JOSH FUNK, Associated Press; NELSON LAMPE, Associated Press | News | Comments

A surgeon who contracted Ebola in his native Sierra Leone received aggressive treatment at a Nebraska hospital over the weekend but died Monday morning. Dr. Martin Salia's death is a reminder of how deadly the Ebola virus is and how important it is to receive treatment early, said Dr. Jeff Gold, chancellor of the University of Nebraska Medical Center in Omaha.


Actavis to Spend $66B on Allergan

November 17, 2014 10:24 am | by TOM MURPHY, AP Business Writer | News | Comments

Actavis will pay $66 billion to buy fellow drugmaker Allergan in a deal that could finally stop a months-long takeover push from Valeant Pharmaceuticals for the Botox maker.             


DEA Agents Raid NFL Medical Staffs after Games

November 17, 2014 8:40 am | by JIM LITKE, AP Sports Writer | News | Comments

Federal drug enforcement agents showed up unannounced Sunday to check at least three visiting NFL teams' medical staffs as part of an investigation into former players' claims that teams mishandled prescription drugs.      


Zoetis to Purchase Assets of Abbott Animal Health

November 17, 2014 8:35 am | News | Comments

Zoetis today announced an agreement to purchase animal health assets of Abbott for a purchase price of $255 million. Abbott Animal Health is a companion animal health business focused on the veterinary surgical suite.      


BMS to Construct a New Large-Scale Biologics Manufacturing Facility in Cruiserath, Ireland

November 17, 2014 8:31 am | News | Comments

Bristol-Myers Squibb Company has announced plans to construct a new state-of-the-art, large-scale biologics manufacturing facility in Cruiserath, County Dublin, Ireland, that will produce multiple therapies for the company’s growing biologics portfolio.


World Bank: Ebola Fund Would Create Incentives

November 17, 2014 8:28 am | by ROD McGUIRK, Associated Press | News | Comments

A proposed global emergency fund to contain the next Ebola outbreak would also provide an incentive for drug companies to develop vaccines to fight other future pandemics, World Bank President Jim Yong Kim said Friday.      


Drug Maker Arrested in India Sterilization Deaths

November 17, 2014 8:25 am | by MUNEEZA NAQVI, Associated Press | News | Comments

Press Trust of India reported that Ramesh Mahawar of Mahawar Pharma Pvt Ltd and his son were arrested and charged with fraud. Police Superintendent O.P. Pal told PTI that the men were arrested on the complaint of food and drug administration officials.


Kentucky Drops Two-Drug Execution Method

November 17, 2014 8:21 am | by BRETT BARROUQUERE, Associated Press | News | Comments

Kentucky is dropping its proposed use of a two-drug execution method after the prolonged deaths of inmates in two other states that used a similar means to carry out death sentences.            



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.